已收盘 05-08 16:00:00 美东时间
+1.060
+6.30%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
累计净回报超2600%!资管公司潘兴广场上市三日累涨超58%;慧荣科技周涨超52%,Q1营收同比翻倍大超预期>>
05-04 18:33
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
NovoCure Ltd.涨27.41%;Impinj, Inc.涨24.95%;Atlassian涨23.36%
05-01 15:01
NovoCure Ltd.涨27.41%;Twilio涨25.18%;Impinj, Inc.涨24.95%
05-01 13:01
NovoCure Ltd.涨26.15%;Twilio涨24.20%;MYR集团涨23.49%
05-01 10:01
NovoCure shares are trading higher after the company reported better-than-expec...
04-30 21:26
NovoCure (NASDAQ:NVCR) released first-quarter financial results and hosted an e...
04-30 21:09
NovoCure (NASDAQ:NVCR) raises FY2026 sales outlook from $675.000 million-$705.000 million to $690.000 million-$710.000 million vs $692.115 million estimate.
04-30 19:32
华盛资讯4月30日讯,NovoCure Ltd.公布2026财年Q1业绩,公司Q1营收1.74亿美元,同比增长12.3%,归母净利润亏损0.71亿美元,同比亏损扩大107.3%。
04-30 19:17